The invention provides a two new human DnaJ-like proteins (HSPJ1 or HSPJ2) and
polynucleotides which identify and encode HSPJ1 or HSPJ2. The invention also provides
expression vectors, host cells, agonists, antibodies and antagonists. The invention
also provides methods for treating disorders associated with expression of HSPJ1
or HSPJ2.
